Bulletin
Investor Alert

London Markets Open in:

Asia Markets Currencies US Market Snapshot

Cassava Sciences Inc.

NAS: SAVA

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Cassava Sciences Inc.

After Hours

SAVA
/zigman2/quotes/204212356/composite

$

45.89

Change

+0.01 +0.02%

Volume

Volume 29,552

Jan 14, 2022, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204212356/composite

Previous close

$ 45.69

$ 45.88

Change

+0.19 +0.42%

Day low

Day high

$44.10

$46.43

Open
Open: 44.93

52 week low

52 week high

$10.90

$146.16

Open

Market cap

$1.84B

Average volume

4.54M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.55

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/sava

MarketWatch News on SAVA

  1. Cassava Sciences stock drops 6.7% premarket, after plunging 59.0% over the past 3 weeks

    7:26 a.m. Sept. 7, 2021

    - Tomi Kilgore

  2. Cassava Sciences stock price target cut to $108 from $145 at B. Riley

    7:23 a.m. Sept. 7, 2021

    - Tomi Kilgore

  6. Cassava Sciences stock bounces 4.5% premarket, after plunging 31.4% on Wednesday

    7:44 a.m. Aug. 26, 2021

    - Tomi Kilgore

  9. Cassava Sciences stock price target raised to $145 from $111 at B. Riley

    6:58 a.m. Aug. 3, 2021

    - Tomi Kilgore

  10. Analyst Raises Price Targets on 3 Smaller Alzheimer's Stocks

    10:50 a.m. July 7, 2021

    - Barron's Online

  11. Cassave Sciences stock price target raised to $190 from $80 at Maxim Group

    7:30 a.m. July 7, 2021

    - Tomi Kilgore

  12. Cassava Sciences started at buy with $78 stock price target at B. Riley

    6:35 a.m. April 27, 2021

    - Tomi Kilgore

  13. The age of the ‘silver stoners’ is nigh

    7:32 a.m. March 20, 2021

    - Brett Arends

  14. Cassava Sciences stock price target raised to $80 from $14 at Maxim Group

    7:53 a.m. Feb. 16, 2021

    - Tomi Kilgore

  15. Treating the Causes, Not Symptoms, of Alzheimer’s

    9:30 p.m. Feb. 12, 2021

    - Barron's Online

  18. Cassava Sciences to offer $200 mln of shares priced at $49 each vs. $50.29 at Tuesday's close

    6:32 a.m. Feb. 10, 2021

    - Ciara Linnane

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/sava

Other News on SAVA

  1. INmune Bio, The Biotech In My Stable For After Cassava Sciences

    11:23 a.m. Jan. 17, 2022

    - Seeking Alpha

  5. Cassava Sciences Has A High Probability Of Failure

    8:00 a.m. Jan. 12, 2022

    - Seeking Alpha

  8. Cassava Sciences: Credibility Issues

    4:15 p.m. Jan. 11, 2022

    - Seeking Alpha

  9. Where Will Cassava Sciences Be in 1 Year?

    7:22 a.m. Jan. 7, 2022

    - Motley Fool

  11. Cassava Sciences, Inc. - The Short Squeeze Has Started

    12:01 p.m. Jan. 6, 2022

    - Seeking Alpha

  12. 3 Healthcare Stocks That Could Rocket Higher in 2022

    11:30 a.m. Jan. 4, 2022

    - Motley Fool

  17. 5 Stocks I'd Sell Right Now

    5:51 a.m. Dec. 29, 2021

    - Motley Fool

  18. Cassava Sciences: Looking At SAVA From Both Sides Now

    7:55 a.m. Dec. 23, 2021

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/sava

Press Releases on SAVA

  7. Cassava Deadline Alert

    6:19 p.m. Oct. 25, 2021

    - Newsfile Corp

  12. Cassava Deadline Alert

    8:29 a.m. Oct. 24, 2021

    - Newsfile Corp

  13. Cassava Update

    8:03 a.m. Oct. 23, 2021

    - Newsfile Corp

  16. Cassava Class Action Reminder

    6:49 p.m. Oct. 21, 2021

    - Newsfile Corp

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Trending Tickers
  • /zigman2/quotes/208747069/composite GEVO+7.77%
  • /zigman2/quotes/228313454/composite CNTX+0.36%
  • /zigman2/quotes/214140886/composite CHPT+5.01%
  • /zigman2/quotes/208173073/composite SFIX+4.61%
  • /zigman2/quotes/222642382/composite OLMA+5.43%
X
Powered by StockTwits
Link to MarketWatch's Slice.